April 18, 2018 Clinical Research/Diagn. Life Science Tools Product Launch

Swift Biosciences Launches Accel-Amplicon™ Plus Cancer Panels for Precision Medicine Initiatives

New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon... Read more

April 17, 2018 Clinical Research/Diagn. Product Launch

Seegene Will Unveil Combination Test at ECCMID 2018

SEOUL, South Korea, April 17, 2018 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, announced that it will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases (“ECCMID 2018”) taking place in Madrid, Spain, from April 21 to 24, 2018, where it will introduce the “combination test,” which is a high-efficiency solution that diagnoses... Read more

April 16, 2018 Atomic Spectroscopy Clinical Research/Diagn. Lab Top-10 Product Launch

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network

Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network CHICAGO, April 16, 2018 /PRNewswire/ — AACR 2018 — One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too little was known about the genetic alterations... Read more

April 16, 2018 Clinical Research/Diagn. Product Launch

GE’s new factory-in-a-box accelerates the production of viral vector based therapeutics

Chalfont St Giles, UK – 17 April 2018 — GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio biomanufacturing facility is designed, constructed, assembled and fully fitted-out to current... Read more

April 16, 2018 Clinical Research/Diagn. Product Launch

GE’s new factory-in-a-box accelerates the production of viral vector based therapeutics

Chalfont St Giles, UK – 17 April 2018 – GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio https://www.genewsroom.com/press-releases/ges-new-factory-box-accelerates-production-viral-vector-based-therapeutics Read more

April 16, 2018 Cell Analysis Tools Clinical Research/Diagn. Product Launch

RareCyte introduces the CyteFinder® HT instrument at AACR for high throughput slide-based imaging optimized for single cell Liquid Biopsy

SEATTLE, April 16, 2018 /PRNewswire/ — RareCyte, Inc., a global rare cell detection and liquid biopsy company, announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest member of the CyteFinder family, enables high-speed whole slide imaging with up to six channels... Read more

April 13, 2018 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies

NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb’s oncology portfolio. The companies plan to develop a diagnostic version of the Illumina TruSight Oncology... Read more

April 12, 2018 Clinical Research/Diagn. Informatics & Software Life Science Tools M&A, Partnerships Product Launch

St. Jude Cloud, largest public repository of pediatric cancer genomics data, launches for researchers worldwide

St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases.   Memphis, Tennessee, April 12, 2018 St. Jude Children’s Research Hospital today launched St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world’s largest... Read more

April 12, 2018 Clinical Research/Diagn. Life Science Tools

Hitachi High-Technologies Capital Partitipation in OmniSeq® Offering Molecular Diagnostic Laboratory Services

Tokyo, Japan, April 12, 2018 – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare... Read more

April 12, 2018 Cell Analysis Tools Clinical Research/Diagn. Lab Top-10 Life Science Tools PR/Corporate

Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR

Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR Company announces next generation Arcturus Cellect LCM System and Oncomine Knowledgebase Reporter update; Scientific presentations to highlight Oncomine assays for tumor mutation load and immune repertoire analysis CARLSBAD, Calif., April 12, 2018 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, will... Read more